Director of Medical Supplies Division and three others arrested
Director of the Medical Supplies Division of the Ministry of Health, Dr. Kapila Wickramanayaka and three others were arrested by the Criminal Investigation Department (CID) over the alleged importing of substandard Immunoglobulin vials, police said.
According to police, they have been arrested over the alleged involvement in importing substandard Immunoglobulin injections using forged documents.
Accordingly, the Director of the Medical Supplies Division Dr. Kapila Wickremenayake, Assistant Director Devashantha Soloman, Accountant (Supplies) Neran Dhananjaya and the Stock Controller of the Medical Supplies Division Sujith Kumara were arrested in relation to the incident, Police Media Spokesman SSP Nihal Thalduwa said.
Isolez Biotech Pharma AG (Pvt.) Ltd., a medicine supplier in the local area, is suspected of importing a batch of human intravenous immunoglobulin (IVIG) using counterfeit documents.
The Sri Lanka Customs discovered this and, on October 13, the Maligakanda Magistrate instructed the CID to conduct a comprehensive investigation.
Hence, the CID launched a thorough investigation resulting in the initial arrest of the owner of the company responsible for importing the substandard Immunoglobulin injections.
UPDATE – 08:40 PM: The Director of the Health Ministry’s Medical Supplies Division, Dr. Kapila Wickramanayaka and three other officials arrested over the controversial Immunoglobulin import, have been remanded until November 29, 2023 by the Maligakanda Magistrate’s Court.
Latest Headlines in Sri Lanka
- Sri Lanka advances economic reforms as IMF review approaches October 25, 2024
- Tension at Pamunugama Police Station over alleged assault on arrested youths October 25, 2024
- Three Chinese nationals arrested in Galle for suspected online financial fraud October 25, 2024
- INSS hosts lecture on military innovations and their impact on national security October 25, 2024
- Sri Lanka arrests three over security threats against Israeli tourists October 24, 2024